On the stock market since 2011, it operates in the world of raw materials. It has 2,477 employees. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 6% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 0.5× for every dollar of annual revenue.
Analysts' average target sits 10% below today's price.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades 21% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 33 buys and 22 sells. Management buying with its own money is usually read as a good sign.
It pays out $0.48 per share each year — regular cash for whoever holds the stock.
A loss of $44.2M against $1.8B in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts about 2 years. After that, the company needs to find new money.
The stock trades 10% above the average analyst price target.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.